Loading
Zoonotic Diseases and Public Health · Journal article
Antimicrobial Resistance and Infection Control · August 30, 2026
Reinforces what was already believed, rather than introducing something new.
This systematic analysis of the Global Burden of Disease Study documents trends in infectious disease and antimicrobial resistance burden in India between 2019 and 2021, showing modest overall declines in deaths and disability while confirming AMR as a substantial source of preventable mortality. The data are country-level epidemiologic estimates derived from standardized surveillance methodology and do not represent a novel intervention or mechanistic finding.
Systematic analysis of Global Burden of Disease Antimicrobial Resistance Study data. India; population-level estimate data stratified by age, sex, infectious syndrome, and pathogen.. Compared with: Comparison of burden between 2019 and 2021. India.
Total infectious disease deaths declined by 5.3% and DALYs by 9.0% between 2019 and 2021 AMR-associated deaths fell from 1.05 million to 0.99 million (−6.0%) AMR-attributable deaths fell from 283,556 to 266,734 (−5.9%)
Greatest reductions in children under five years; adults aged 60+ accounted for increasing share of AMR-attributable mortality
Clinicians and public health professionals should recognize that despite recent modest declines, antimicrobial resistance remains a major cause of preventable mortality in India, particularly in older adults, and warrants continued investment in surveillance, antimicrobial stewardship, and pathogen-specific prevention strategies.
Systematic analysis of established surveillance data (GBD Study) showing documented trends in infectious disease and AMR burden in India; confirms the ongoing epidemiologic importance of AMR with quantified changes, but is a descriptive epidemiologic study, not an intervention trial or novel mechanistic finding.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians and public health professionals should recognize that despite recent modest declines, antimicrobial resistance remains a major cause of preventable mortality in India, particularly in older adults, and warrants continued investment in surveillance, antimicrobial stewardship, and pathogen-specific prevention strategies.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Infectious diseases and antimicrobial resistance (AMR) remain one of the major causes of mortality and disability in India. But age- and pathogen-specific evidence on recent changes in AMR burden is limited. We analysed India-specific data from the Global Burden of Disease Antimicrobial Resistance Study to quantify changes in infectious disease and AMR-related deaths and disability-adjusted life years (DALYs) between 2019 and 2021. Deaths and DALYs, both associated with and attributable to AMR, were examined across 11 infectious syndromes, major bacterial pathogens, across age groups, and sex. Between 2019 and 2021, total infectious disease deaths declined by 5.3% and DALYs by 9.0%. AMR-associated deaths fell from 1.05 million to 0.99 million (− 6.0%), and AMR-attributable deaths from 283,556 to 266,734 (− 5.9%). Reductions were greatest among children under five years, while adults aged 60 years and older accounted for an increasing share of AMR-attributable mortality. Bloodstream and lower respiratory infections remained the dominant contributors. Despite overall declines, AMR continues to account for a substantial proportion of preventable deaths in India, highlighting the need for strengthened surveillance, age-targeted antimicrobial strategy, and pathogen-specific interventions.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.